NEW YORK (GenomeWeb) – Transgenomic announced today that it has signed an agreement for its ICE-COLD PCR technology with Canadian laboratory services LifeLabs.

Under the terms of the three-year deal, LifeLabs will have a non-exclusive license to the technology and use it in its mutation enrichment platform for cancer testing. The renewable agreement, Transgenomic said, allows LifeLab to benefit from technology improvements and additional product launches during its term.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.